DSIP does not solve this alone
Weekly check-ins help keep you on track, provide space to ask questions, and allow for thoughtful plan adjustments
In some embodiments, the formulations or compositions described herein have a pH and osmolarity as described herein, and have a concentration of active pharmaceutical ingredient between about 0.01-about 20%, between about 0.01-about 10%, between about 0.01-about 7%, between about 0.01-5%, between about 0.01-about 3%, between about 0.01-about 2% of the active ingredient by weight of the formulation or composition
This is one of the primary risks associated with using experimental peptides from the grey market
Afterward, a compression injury was induced and the same area was imaged for an additional 9 hrs
For tennis elbow, golfers elbow, and other elbow tendon injuries, typical research protocols use 0.25 to 0.5 mg daily via subcutaneous injection near the injury site for 4 to 8 weeks